×banner icon

Replay - Spirometry and Feno, Important diagnostic and monitoring tools for the Asthmatic patient.

243 reviews
Vyaire Medical

Vyaire Medical

See more
  • Pulmonology, Respiratory Therapist
  • 1h
  • English

Training details

There is increasing evidence that asthma is a heterogeneous pathological condition characterized by different phenotypes/endotypes related to specific pathological pathways. Exhaled nitric oxide (FeNO), is a biomarker of one pathologic pathway, allergic airway inflammation, that has proven helpful to predict therapeutic response in selected asthmatic populations. FeNO is a quantitative, non-invasive, simple and safe method of measuring allergic airway inflammation that provides a complementary tool to other ways of assessing airway disease in asthma patients including spirometry and as part of the diagnostic algorithm for both children over 5 and adults with respiratory symptoms suggestive of asthma, but has also demonstrated utility for managing asthma and selecting therapies for this disease. A common question is “How do FeNO and spirometry complement each other and why do I need both?” 

During this webinar, our speaker Dr. Philip E Silkoff will try and answer this question by reviewing the current evidence on the relationship between FeNO & Spirometry and how these tools can be used together for the Asthmatic patients. 

Educational methods

E-learning course


Spirometry & Feno

  • 1 h


Global review

4.4 / 5


4.4 / 5


4.5 / 5

Knowledge acquired

4.3 / 5


4.5 / 5


Rudy D.



Abdul G.


Kristie M.


Jim S.

I am very pleased with the quality of this presentation and I have forwarded this to several colleagues (Respiratory Therapists & RPFTs) as well as pulmonary physicians. Thank you!


Elizabeth Q.


Sabrina H.